Cargando…

Oxidative stress promotes d-GalN/LPS-induced acute hepatotoxicity by increasing glycogen synthase kinase 3β activity

OBJECTIVE: Our previous studies have demonstrated that glycogen synthase kinase 3β (GSK3β) activity is increased in the progression of acute liver failure (ALF), which aggravates liver injury, while its regulatory mechanism remains elusive. This study is designated to address whether oxidative stres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Linlin, Ren, Feng, Zhang, Xiangying, Wen, Tao, Shi, Hongbo, Zheng, Sujun, Zhang, Jing, Chen, Yu, Han, Yuanping, Duan, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Basel 2014
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018480/ https://www.ncbi.nlm.nih.gov/pubmed/24531650 http://dx.doi.org/10.1007/s00011-014-0720-x

Ejemplares similares

Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis
por: Chen, Liyan, et al.
Publicado: (2012)

Distinct effects of different doses of kaempferol on D-GalN/LPS-induced ALF depend on the autophagy pathway
por: Tian, Yuan, et al.
Publicado: (2021)

Complement and the Alternative Pathway Play an Important Role in LPS/D-GalN-Induced Fulminant Hepatic Failure
por: Sun, Shihui, et al.
Publicado: (2011)

BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats
por: Yan, Dan, et al.
Publicado: (2016)

Deletion of caveolin‐1 attenuates LPS/GalN‐induced acute liver injury in mice
por: Tsai, Tsung‐Huang, et al.
Publicado: (2018)

Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells
por: Yang, Sen, et al.
Publicado: (2020)

Prevention of D-GalN/LPS-induced ALI by 18β-glycyrrhetinic acid through PXR-mediated inhibition of autophagy degradation
por: Wu, Shouyan, et al.
Publicado: (2021)

Exacerbated LPS/GalN-Induced Liver Injury in the Stress-Sensitive Wistar Kyoto Rat Is Associated with Changes in the Endocannabinoid System
por: Killilea, Marykate, et al.
Publicado: (2020)

Protective Effects of p-CA Against Acute Liver Damage Induced by LPS/D-GalN in Wistar Albino Rats
por: Mehdi, Seerat, et al.
Publicado: (2022)

Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity
por: Regmi, Shobha, et al.
Publicado: (2019)

Swertia cincta Burkill alleviates LPS/D-GalN-induced acute liver failure by modulating apoptosis and oxidative stress signaling pathways
por: Wu, Xinyan, et al.
Publicado: (2023)

Glycogen synthase kinase-3β inhibitor reduces LPS-induced acute lung injury in mice
por: Ding, Qi, et al.
Publicado: (2017)

Domino hepatocyte transplantation using explanted human livers with metabolic defects attenuates D-GalN/LPS-induced acute liver failure
por: Zhou, Guang-Peng, et al.
Publicado: (2022)

Identification of key immune-related genes associated with LPS/D-GalN-induced acute liver failure in mice based on transcriptome sequencing
por: Chen, Ling, et al.
Publicado: (2023)

Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis
por: Li, Ruidong, et al.
Publicado: (2021)

Lupeol ameliorates LPS/D-GalN induced acute hepatic damage by suppressing inflammation and oxidative stress through TGFβ1-Nrf2 signal pathway
por: Huang, Sha, et al.
Publicado: (2021)

Anti-inflammation and anti-apoptosis effects of growth arrest-specific protein 6 in acute liver injury induced by LPS/D-GalN in mice
por: Wang, Qian, et al.
Publicado: (2020)

The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis
por: Liu, Shuhui, et al.
Publicado: (2022)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

UMSCs Attenuate LPS/D-GalN-induced Acute Liver Failure in Mice by Down-regulating the MyD88/NF-κB Pathway
por: Liao, Hailing, et al.
Publicado: (2021)

Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis
por: Zheng, Hanxue, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice
por: Huang, Yin-Qiu, et al.
Publicado: (2016)

Apoptotic Response through a High Mobility Box 1 Protein-Dependent Mechanism in LPS/GalN-Induced Mouse Liver Failure and Glycyrrhizin-Mediated Inhibition
por: Kuroda, Noriyuki, et al.
Publicado: (2014)

Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway
por: Tao, Ya-Chao, et al.
Publicado: (2019)

Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway
por: Zhou, Ziyuan, et al.
Publicado: (2023)

Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor
por: Noori, Mahboubeh S., et al.
Publicado: (2020)

Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
por: Liu, Yimei, et al.
Publicado: (2022)

Eriodictyol Alleviated LPS/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Cell Apoptosis via PI3K/AKT Signaling Pathway
por: Zheng, Xiaomei, et al.
Publicado: (2023)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

Luteolin and luteolin-7-O-glucoside protect against acute liver injury through regulation of inflammatory mediators and antioxidative enzymes in GalN/LPS-induced hepatitic ICR mice
por: Park, Chung Mu, et al.
Publicado: (2019)

Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury via the TLR4/NF-κB Pathway
por: Qu, Xiao-qin, et al.
Publicado: (2022)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?
por: Koistinaho, Jari, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7ipr8ccgmkf9k2ia8em8ctn1md